HomeANVS • NYSE
add
Annovis Bio Inc
Previous close
$7.08
Day range
$6.91 - $7.36
Year range
$4.79 - $22.49
Market cap
81.44M USD
Avg Volume
872.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.81M | -21.66% |
Net income | -1.07M | 89.04% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.14M | -81.28% |
Total assets | 7.81M | -69.42% |
Total liabilities | 11.17M | 106.37% |
Total equity | -3.35M | — |
Shares outstanding | 11.17M | — |
Price to book | -23.60 | — |
Return on assets | -216.68% | — |
Return on capital | 351.64% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -1.07M | 89.04% |
Cash from operations | -7.03M | 39.51% |
Cash from investing | — | — |
Cash from financing | 4.42M | 59,675.25% |
Net change in cash | -2.62M | 77.47% |
Free cash flow | -4.15M | 48.91% |
About
Founded
2008
Headquarters
Website
Employees
6